Staubach, P
Diagnostik und Therapie verschiedener UrtikariaformenMedReport. Bd. 30. H. 26. 2006 S. 12
Lopez-Kostka, S; Knop, J; Konur, A et al.
Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.J Invest Dermatol. Bd. 126. H. 7. 2006 S. 1582-9
Steitz, J; Britten, CM; Wolfel, T et al.
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.Cancer Immunol Immunother. Bd. 55. H. 3. 2006 S. 246-53
Steitz, J; Buchs, S; Tormo, D et al.
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.Int J Cancer. Bd. 118. H. 2. 2006 S. 373-80
Bork, K; Gül, D; Dewald, G
Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men.Br J Dermatol. Bd. 154. H. 3. 2006 S. 542-545
Bork, K
Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.Immunol Allergy Clin North Am. Bd. 26. H. 4. 2006 S. 709-24
Longhurst, HJ; Bork, K
Hereditary angioedema: causes, manifestations and treatment.Hosp Med. Bd. 67. H. 12. 2006 S. 654-657
Bork, K; Meng, G; Staubach, P et al.
Hereditary angioedema: new findings concerning symptoms, affected organs, and course.Am J Med. Bd. 119. H. 3. 2006 S. 267-74
Jansen, T; Grabbe, S
Im Schnitt zehn Jahre bis zur richtigen Diagnose. Kennen Sie die Zeichen des Morbus Fabry?MMW Fortschr Med. Bd. 148. H. 48. 2006 S. 46-7
Cichon, S; Martin, L; Hennies, HC et al.
Increased activity if coagulation factor XII (Hageman factor) causes hereditary angioedema type III.Am J Hum Genet. Bd. 79. H. 6. 2006 S. 1098-1104
Weigmann, B; Jarman, ER; Sudowe, S et al.
Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity.J Invest Dermatol. Bd. 126. 2006 S. 1524-1533
Tüttenberg, A; Becker, C; Hüter, E et al.
Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.Int J Cancer. Bd. 118. 2006 S. 2617-2627
Bellinghausen, I; König, B; Böttcher, I et al.
Inhibition of human allergic T-helper type I immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.Clin Exp Allergy. Bd. 36. H. 12. 2006 S. 1546-1555
Warger, T; Hilf, N; Rechtsteiner, G et al.
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.J Biol Chem. Bd. 281. H. 32. 2006 S. 22545-53
Bellinghausen, I; Sudowe, S; Konig, B et al.
Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.Int Arch Allergy Immunol. Bd. 141. H. 1. 2006 S. 61-9
Hillen, U; Jappe, U; Frosch, PJ et al.
Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group.Br J Dermatol. Bd. 154. H. 4. 2006 S. 665-70
Seidel-Guyenot, W; Perschon, S; Dechant, N et al.
Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation.J Allergy Clin Immunol. Bd. 117. H. 5. 2006 S. 1170-7
Bellinghausen, I; Knop, J; Saloga, J
Mechnisms of specific immunotherapy.Hautarzt. Bd. 57. H. 10. 2006 S. 855-859
Dewald, G; Bork, K
Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor.Biochem Biophys Res Commun. Bd. 343. H. 4. 2006 S. 1286-1289
Sudowe, S; Urbanczyk, A; Stahl, B et al.
Modulation of dendritic cell differentiation and maturation by dietary probioticsAllergo J. Bd. 15. 2006 S. 40
Jansen, T; Mengel, E; Beck, M et al.
Morbus Gaucher. Eine Stoffwechselstoerung mit typischen kutanen ManifestationenDer Deutsche Dermatologe. Bd. 3. 2006 S. 166
Geier, J; Lessmann, H; Becker, D et al.
Patch testing with components of water-based metalworking fluids: results of a multicentre study with a second series.Contact Dermatitis. Bd. 55. H. 6. 2006 S. 322-9
Vollmann, D; Erdogan, A; Himmrich, E et al.
Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.Europace. Bd. 8. H. 5. 2006 S. 371-6
Sudowe, S; Ludwig-Portugall, I; Montermann, E et al.
Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.J Allergy Clin Immunol. Bd. 117. 2006 S. 196-203
Chromik, J; Schnurer, E; Meyer, RG et al.
Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.J Immunol Methods. Bd. 308. H. 1-2. 2006 S. 77-89